2019

Medical device 'HuriCell®' approved by TFDA (Thailand)

Medical device 'HuriCell®' approved by JFDA (Jordan)

Awarded 'Venture Business Minister Prize' from KISI

2018

The capital increment from 'A+Life INC' (2 billion KRW)

Awarded a 'New Regenerative Medical Device Prize' from a minister of MFDS

Acquired GMP certification for medical device

2017

Established a strategic partnership with 'A+Life INC' for cell banking business

2014

'HuriCell®' listed as class Ⅲ medical device by MFDS

2013

Completed state-funded researching project of vitiligo therapy

2012

Completed state-funded researching project of liver disease therapy

Commercialization of 'HuriCell®' (Automatic SVF Isolator)

2011

Acquired umbilical cord blood bank qualification from MOHW

2010

Developed 'Ideal cryopreservation for stem cells using ice active substances' based on a national study from the government (MOE)

2009

Awarded as 'New technology & Industry Pioneer.'

Completed state-funded researching project of liver disease therapy (TIE,1st Stage)

2008

Joint research contract on vitiligo medicine development with Dong-guk university

2007

Developed differentiation technology of ADSC, CDSC to liver cells and muscle cells, as well as culture solution

2006

Acquired R&D lab qualification from MOHW

Genetic research institute approval from MOHW

Acquired Venture Company license from KMSS

2005

Establishment of HURIM BIOCELL INC

Establishment of 'Help Cell Bank'